UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 26, 2026
Sale
Calculated transaction value
$395.31K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 23, 2026
Public filing date
Oct 26, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$587.5
Oct 23, 2026
First close after public filing
$591.2
Oct 27, 2026
Return after filing · so far
-3.15%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 676 shares @ $584.77
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000171
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.65M
Buys / sales
0 / 11
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 23, 2026 | $435.12K |
| United Therapeutics Corp UTHR | Exercise | Oct 23, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 23, 2026 | $960.01K |
| United Therapeutics Corp UTHR | Sale | Oct 23, 2026 | $590.65K |
| United Therapeutics Corp UTHR | Sale | Oct 23, 2026 | $249.3K |
| United Therapeutics Corp UTHR Current | Sale | Oct 23, 2026 | $395.31K |
| United Therapeutics Corp UTHR | Sale | Oct 23, 2026 | $115.54K |
| United Therapeutics Corp UTHR | Sale | Oct 23, 2026 | $601.77K |
| United Therapeutics Corp UTHR | Sale | Oct 23, 2026 | $1.01M |
| United Therapeutics Corp UTHR | Sale | Oct 23, 2026 | $318.11K |
| United Therapeutics Corp UTHR | Sale | Oct 23, 2026 | $405.16K |
| United Therapeutics Corp UTHR | Sale | Oct 23, 2026 | $455.9K |
| United Therapeutics Corp UTHR | Exercise | Oct 23, 2026 | $0 |